Literature DB >> 10482981

Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia.

S D Raynaud1, N Dastugue, D Zoccola, S A Shurtleff, S Mathew, S C Raimondi.   

Abstract

The t(12;21)(p13;q22) is a cryptic abnormality observed in 25% of children with B-lineage acute lymphoblastic leukemia (ALL), associated with a favorable prognosis. To determine whether specific cytogenetic abnormalities accompany the t(12;21), we analyzed the cytogenetic profiles of blast cells from 169 ALL cases positive for the t(12;21), previously identified by molecular methods. Only 13.6% of samples had normal karyotypes. Structural changes were detected in 89.7% of abnormal karyotypes, and numerical abnormalities in 47%. Rearrangements of 12p were the most frequent structural aberration (57 out of 146 patients with chromosomal abnormalities). Nonspecific deletions of chromosomes 6 and 9 were also found. The most frequent numerical abnormalities was trisomy for chromosomes 21. Blast cells were pseudodiploid (45.6%), hyperdiploid with 47 to 51 chromosomes (24.3%), hypodiploid with 44 to 45 chromosomes (10%), near-triploid (0.6%), or near-tetraploid (5.9%). Our results show that the t(12;21) is not associated with hyperdiploidy of 52 to 68 chromosomes or with the prognostic t(1;19), t(4;11) or t(9;22). Only children with B-lineage ALL who lack these abnormalities detected by conventional cytogenetics will probably benefit from additional testing by molecular methods to detect the t(12;21).

Entities:  

Mesh:

Year:  1999        PMID: 10482981     DOI: 10.1038/sj.leu.2401506

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

1.  Guidance for fluorescence in situ hybridization testing in hematologic disorders.

Authors:  Daynna J Wolff; Adam Bagg; Linda D Cooley; Gordon W Dewald; Betsy A Hirsch; Peter B Jacky; Kathleen W Rao; P Nagesh Rao
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 2.  Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia.

Authors:  Dan Douer
Journal:  Oncologist       Date:  2016-06-21

3.  BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Authors:  Karen A Dun; Rob Vanhaeften; Tracey J Batt; Louise A Riley; Giuseppe Diano; Jan Williamson
Journal:  Blood Adv       Date:  2016-11-30

4.  Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia.

Authors:  Hee Yeon Woo; Dae Won Kim; Hyosoon Park; Ki Woong Seong; Hong Hoe Koo; Sun Hee Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

5.  Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea.

Authors:  Jae Wook Lee; Seong-Koo Kim; Pil-Sang Jang; Nack-Gyun Chung; Dae-Chul Jeong; Myungshin Kim; Bin Cho; Hack-Ki Kim
Journal:  Cancer Res Treat       Date:  2016-08-10       Impact factor: 4.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.